• Medipal Holdings' board resolved on October 23, 2026, to repurchase and cancel treasury stock.
• The buyback covers up to 4,000,000 common shares, representing 2% of outstanding shares excluding treasury stock.
• Total acquisition cost is capped at 10 billion.
• Purchases on the Tokyo Stock Exchange will run from November 6, 2026, to March 31, 2027.
• All shares acquired will be canceled by March 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medipal Holdings Corporation published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.